Prevalence of the Trp64Arg missense mutation of the β3-adrenergic receptor gene in Japanese subjects

Metabolism: Clinical and Experimental

Volumn 46, Issue 2, 1997, Pages 199-202

  Ueda, Kohei ^b   Tanizawa, Yukio ^a   Oota, Yasuharu ^b   Inoue, Hirohumi ^b   Kizuki, Nobuaki ^b   Inoue, Hiroshi ^b   Tsukuda, Katsunori ^b   Asano, Tomoichiro ^b   Oka, Yoshitomo ^b  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR; INSULIN;

ADULT; AGED; ARTICLE; BODY MASS; DIABETOGENESIS; DYSLIPIDEMIA; FEMALE; HUMAN; INSULIN RELEASE; JAPAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ONSET AGE; PREVALENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 0031048994     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(97)90302-4     Document Type: Article

References (21)

1. DeFronzo RA: The triumvirate: β-Cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37:667-687, 1988
2. Barrett-Connor E: Epidemiology, obesity, and non-insulin-dependent diabetes mellitus. Epidemiol Rev 11:172-181, 1989
3. Pouliot M-C, Despres J-P, Nadeau A, et al: Visceral obesity in men: Associations with glucose tolerance, plasma insulin, and lipoprotein levels. Diabetes 41:826-834, 1992
4. Caro JF: Insulin resistance in obese and nonobese man. J Clin Endocrinol Metab 73:691-695, 1991
5. Griffiths M, Payne PR, Stunkard AJ, et al: Metabolic rate and physical development in children at risk of obesity. Lancet 336:76-78, 1990
6. Ravussin E, Lillioja S, Knowler WC, et al: Reduced rate of energy expenditure as a risk factor for body-weight gain. N Engl J Med 318:467-472, 1988
7. 3 and atypical β-adrenoceptors. Med Res Rev 13:663-729, 1993
8. 3-adrenergic receptor mRNA in man. J Clin Invest 91:344-349, 1993
9. 3-adrenergic receptor. Science 245:1118-1121, 1989
10. 3-adrenergic receptors in obesity. J Clin Invest 95:1109-1116, 1995
11. Susulic VS, Frederick RC, Lawitts J, et al: Targeted disruption of the beta 3-adrenergic receptor gene. J Biol Chem 270:29483-29492, 1995
12. 3-adrenergic receptor gene. N Engl J Med 333:343-347, 1995
13. 3-adrenergic receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 333:348-351, 1995
14. 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med 333:352-354, 1995
15. 3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. Biochem Biophys Res Commun 215:555-560, 1995
16. 3-adrenergic-receptor with NIDDM and body weight gain. Diabetologia 39:349-352, 1996
17. 3-adrenergic receptor in Japanese NIDDM patients. Diabetes Care 19:271-272, 1996
18. Kosaka K, Hagura R, Kuzuya T: Insulin responses in equivocal and definite diabetes, with special reference to subjects who had mild glucose intolerance but later developed definite diabetes. Diabetes 26:944-952, 1987
19. Noda K, Matsutani A, Tanizawa Y, et al: Polymorphic microsatellite repeat markers at the glucokinase gene locus are positively associated with NIDDM in Japanese. Diabetes 42:1147-1152, 1993
20. Kaplan NM: The deadly quartet; Upper body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 149:1514-1520, 1989
21. Fujioka S, Matsuzawa Y, Tokunaga K, et al: Contribution of intraabdominal visceral fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 36:54-59, 1987